name,category,termsCD34 molecule,BBID[10000090$7.IL17_hematopoesis]
CD34 molecule,BIOCARTA[30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes]
CD34 molecule,INTERPRO[450007419$IPR008083:CD34 antigen, 450012437$IPR013836:CD34/Podocalyxin]
CD34 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage]
CD34 molecule,PIR_SUPERFAMILY[630021618$PIRSF028749:sialomucin CD34]
CD34 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790000983$monomer, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
CD34 molecule,UP_SEQ_FEATURE[850023257$chain:Hematopoietic progenitor cell antigen CD34, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
GTPase, IMAP family member 8,INTERPRO[450006113$IPR006703:AIG1]
GTPase, IMAP family member 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000639$gtp-binding, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism]
GTPase, IMAP family member 8,UP_SEQ_FEATURE[850022640$chain:GTPase IMAP family member 8, 850102576$compositionally biased region:Poly-Leu, 850102585$compositionally biased region:Poly-Val, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
REST corepressor 2,INTERPRO[450000828$IPR000949:ELM2, 450000876$IPR001005:SANT, DNA-binding, 450010997$IPR012287:Homeodomain-related, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
REST corepressor 2,SMART[760000623$SM00717:SANT]
REST corepressor 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
REST corepressor 2,UP_SEQ_FEATURE[850057313$chain:REST corepressor 2, 850102586$compositionally biased region:Pro-rich, 850103712$domain:ELM2, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850117294$sequence conflict, 850117295$sequence variant]
S100 calcium binding protein A7A,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A7A,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A7A,SP_PIR_KEYWORDS[790000012$acetylation, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
S100 calcium binding protein A7A,UP_SEQ_FEATURE[850000624$calcium-binding region:2; high affinity, 850047567$chain:Protein S100-A7A, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117295$sequence variant]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,INTERPRO[450002837$IPR003228:Transcription initiation factor TFIID, 450008207$IPR009072:Histone-fold]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,UP_SEQ_FEATURE[850065451$chain:Transcription initiation factor TFIID subunit 12, 850105852$helix, 850106258$modified residue, 850118574$splice variant]
TBC1 domain family, member 12,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 12,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 12,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein]
TBC1 domain family, member 12,UP_SEQ_FEATURE[850063653$chain:TBC1 domain family member 12, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850117294$sequence conflict]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,INTERPRO[450002359$IPR002659:Glycosyl transferase, family 31]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,UP_SEQ_FEATURE[850068198$chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chemokine (C-C motif) ligand 26,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 26,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-C motif) ligand 26,OMIM_DISEASE[520001811$Esophagitis, eosinophilic, susceptibility to, 520001812$Esophagitis, eosinophilic, susceptibility to}. 610247]
chemokine (C-C motif) ligand 26,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types]
chemokine (C-C motif) ligand 26,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 26,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000775$inflammatory response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 26,UP_SEQ_FEATURE[850008619$chain:C-C motif chemokine 26, 850102883$disulfide bond, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chromosome 1 open reading frame 194,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 194,UP_SEQ_FEATURE[850073634$chain:Uncharacterized protein C1orf194, 850118574$splice variant]
coiled-coil domain containing 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 62,UP_SEQ_FEATURE[850012031$chain:Coiled-coil domain-containing protein 60, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
complement component (3d/Epstein Barr virus) receptor 2,BBID[10000080$6.CD23_engagement]
complement component (3d/Epstein Barr virus) receptor 2,BIOCARTA[30000040$h_blymphocytePathway:B Lymphocyte Cell Surface Molecules]
complement component (3d/Epstein Barr virus) receptor 2,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450014444$IPR016060:Complement control module]
complement component (3d/Epstein Barr virus) receptor 2,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway]
complement component (3d/Epstein Barr virus) receptor 2,OMIM_DISEASE[520004782$Systemic lupus erythematosus, susceptibility to, 9]
complement component (3d/Epstein Barr virus) receptor 2,PIR_SUPERFAMILY[630002601$PIRSF002484:complement C3d/Epstein-Barr virus receptor]
complement component (3d/Epstein Barr virus) receptor 2,SMART[760000024$SM00032:CCP]
complement component (3d/Epstein Barr virus) receptor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000763$immune response, 790000777$innate immunity, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001471$sushi, 790001478$systemic lupus erythematosus, 790001555$transmembrane, 790001556$transmembrane protein]
complement component (3d/Epstein Barr virus) receptor 2,UP_SEQ_FEATURE[850012398$chain:Complement receptor type 2, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105417$domain:Sushi 10, 850105418$domain:Sushi 11, 850105419$domain:Sushi 12, 850105420$domain:Sushi 13, 850105421$domain:Sushi 14, 850105422$domain:Sushi 15, 850105429$domain:Sushi 2, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105448$domain:Sushi 6, 850105449$domain:Sushi 7, 850105450$domain:Sushi 8, 850105451$domain:Sushi 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cysteine/histidine-rich 1,INTERPRO[450001138$IPR001293:Zinc finger, TRAF-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
cysteine/histidine-rich 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
cysteine/histidine-rich 1,UP_SEQ_FEATURE[850013241$chain:Cysteine and histidine-rich protein 1, 850118574$splice variant, 850118920$zinc finger region:RING-type; degenerate, 850118936$zinc finger region:TRAF-type]
cytohesin 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor]
cytohesin 1,INTERPRO[450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
cytohesin 1,PIR_SUPERFAMILY[630005444$PIRSF005519:cytohesin]
cytohesin 1,SMART[760000194$SM00222:Sec7, 760000205$SM00233:PH]
cytohesin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor]
cytohesin 1,UP_SEQ_FEATURE[850013985$chain:Cytohesin-1, 850104979$domain:PH, 850105336$domain:SEC7, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
death effector domain containing 2,INTERPRO[450001658$IPR001875:Death effector]
death effector domain containing 2,SMART[760000023$SM00031:DED]
death effector domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
death effector domain containing 2,UP_SEQ_FEATURE[850015883$chain:DNA-binding death effector domain- containing protein 2, 850103511$domain:DED, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
deformed epidermal autoregulatory factor 1 (Drosophila),INTERPRO[450000665$IPR000770:SAND, 450002557$IPR002893:Zinc finger, MYND-type, 450009947$IPR010919:SAND-like]
deformed epidermal autoregulatory factor 1 (Drosophila),SMART[760000230$SM00258:SAND]
deformed epidermal autoregulatory factor 1 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001016$neurogenesis, 790001065$nucleus, 790001162$phosphoprotein, 790001363$Secreted, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
deformed epidermal autoregulatory factor 1 (Drosophila),UP_SEQ_FEATURE[850014658$chain:Deformed epidermal autoregulatory factor 1 homolog, 850102378$compositionally biased region:Ala-rich, 850102586$compositionally biased region:Pro-rich, 850105253$domain:SAND, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118853$zinc finger region:MYND-type]
ets variant 6,INTERPRO[450000358$IPR000418:Ets, 450002742$IPR003118:Sterile alpha motif/pointed, 450010816$IPR011991:Winged helix repressor DNA-binding, 450012380$IPR013761:Sterile alpha motif-type]
ets variant 6,KEGG_PATHWAY[470038847$hsa04320:Dorso-ventral axis formation]
ets variant 6,OMIM_DISEASE[520002840$Leukemia, acute myeloid, somatic, 520003072$Many sequence variants affecting diversity of adult human height, 520003472$myeloproliverative disorder, chronic, with eosinophilia]
ets variant 6,SMART[760000223$SM00251:SAM_PNT, 760000360$SM00413:ETS]
ets variant 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 6,UP_SEQ_FEATURE[850065163$chain:Transcription factor ETV6, 850102913$DNA-binding region:ETS, 850105048$domain:PNT, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117872$site:Breakpoint for translocation to form CHIC2-ETV6 in AML, 850117877$site:Breakpoint for translocation to form ETV6-AML1 in ALL, 850117878$site:Breakpoint for translocation to form ETV6-MDS2 in MDS, 850117922$site:Breakpoint for translocation to form PAX5-ETV6, 850118575$strand, 850118624$turn]
growth hormone 2,INTERPRO[450001245$IPR001400:Somatotropin hormone, 450011046$IPR012351:Four-helical cytokine, core, 450016416$IPR018116:Somatotropin hormone, conserved site]
growth hormone 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
growth hormone 2,PIR_SUPERFAMILY[630001964$PIRSF001825:prolactin/lactogen/growth hormone]
growth hormone 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000708$hormone, 790001189$placenta, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth hormone 2,UP_SEQ_FEATURE[850022468$chain:Growth hormone variant, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
interleukin 1 family, member 9,INTERPRO[450000847$IPR000975:Interleukin-1, 450002876$IPR003297:Interleukin-1 receptor antagonist IL1RA]
interleukin 1 family, member 9,SMART[760000107$SM00125:IL1]
interleukin 1 family, member 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000402$cytokine, 790001212$polymorphism, 790001363$Secreted]
interleukin 1 family, member 9,UP_SEQ_FEATURE[850026496$chain:Interleukin-1 family member 9, 850117295$sequence variant, 850118574$splice variant]
late cornified envelope 1A,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization]
late cornified envelope 1A,UP_SEQ_FEATURE[850028020$chain:Late cornified envelope protein 1A, 850102480$compositionally biased region:Cys-rich]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,INTERPRO[450000779$IPR000892:Ribosomal protein S26e]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,PIR_SUPERFAMILY[630002282$PIRSF002153:ribosomal protein S26]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,UP_SEQ_FEATURE[850002020$chain:40S ribosomal protein S26, 850106258$modified residue, 850117294$sequence conflict]
splA/ryanodine receptor domain and SOCS box containing 2,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
splA/ryanodine receptor domain and SOCS box containing 2,SMART[760000225$SM00253:SOCS, 760000394$SM00449:SPRY]
splA/ryanodine receptor domain and SOCS box containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001593$ubl conjugation pathway]
splA/ryanodine receptor domain and SOCS box containing 2,UP_SEQ_FEATURE[850062256$chain:SPRY domain-containing SOCS box protein 2, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850105852$helix, 850118575$strand, 850118624$turn]
